Rare condition

Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency

0

studies recruiting now

as of 7 Sept 2026

0

studies registered in total

as of 7 Sept 2026

0

countries with a recruiting site

as of 7 Sept 2026

None

recruiting study posted to date

among recruiting studies

Recruiting trials

No registered studies found for Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency.

ClinicalTrials.gov has no study listed under this name as of 7 Sept 2026. That can change, and there are other routes worth knowing about.

Keep watching

Get an email when a new Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency study opens.

One email a day at most. Unsubscribe with one click.

Used only for these alerts. Privacy.

Support

Patient organisations

We do not yet list a dedicated organisation for this condition. The directories below are the best route.

About Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency

RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the gene involved (CYP7A1).

Treatments being studied

26 approved treatments and 31 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.

Approved: Ezetimibe (Ezetimibe)Approved: Fenofibric Acid (Fenocor-67)Approved: Inclisiran Sodium (Leqvio)Approved: Pravastatin Sodium (Elisor)Approved: Rosuvastatin Calcium (Crestor)Approved: Evinacumab (Evkeeza)Approved: Simvastatin (Flolipid)Approved: Lomitapide Mesylate (Juxtapid)Approved: Amlodipine Besylate (Amlodipine besylate)Approved: Pitavastatin (Pitavastatin component of k-924 pivastatin)Approved: RosuvastatinApproved: Colestipol Hydrochloride (Colestid)Approved: Bempedoic Acid (Bempedoic acid component of nexlizet)Approved: Evolocumab (Repatha)Approved: Cholestyramine (Cholestyramine)Approved: Colesevelam Hydrochloride (Cholestagel)Approved: Pitavastatin Calcium (Livalo)Approved: Atorvastatin Calcium (Atorvaliq)Approved: Fluvastatin Sodium (Dorisin xl)Approved: Pitavastatin Magnesium (Zypitamag)Approved: InclisiranApproved: Alirocumab (Praluent)Approved: Niacin (Niacin)Approved: Fenofibrate (Antara)Approved: Lovastatin (Altoprev)Approved: Atorvastatin (Cardyl)
Phase 3Irbesartan (Aprovel)
Phase 3Enlicitide Decanoate
Phase 3Torcetrapib
Phase 3Anacetrapib
Phase 3Mipomersen Sodium (Kynamro)
Phase 3Lerodalcibep
Phase 3Tafolecimab
Phase 3K-877

+ 23 more in development

Related conditions

Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).